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Abstract 
With the goal of creating a porphyrin we reacted isoquinol pyrrole, p-fluorobenzaldehyde, and boron 
trifluoride etherate under appropriate conditions.  Instead of a porphyrin being synthesized, we created 
polyisoquinol pyrrole in high yield and with great absorption properties around 600nm.  We characterized 
this compound via UV/vis spectroscopy, proton NMR, and electrochemistry.  The compound was then 
reacted with [Ru(bipy)2Cl2] to create a cationic compound and this molecule was tested as a possible 
photosensitizer for photodynamic therapy (PDT) but it was unable to photocleave plasmid DNA above 
550nm.  The original compound was then methylated and this new compound was also tested as a 
photosensitizer.  This complex was successful at photocleaving DNA above 550nm and appears to be a 
promising photosensitizer. 
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Introduction 
 
 Photodynamic therapy (PDT) has been known for many years but is currently 
gaining popularity due to its ability to fight many different cancers with minimal 
side effects.  PDT is an efficient procedure for many different cancers ranging 
from skin and esophageal, to bladder, breast, and lung cancer.1-3  Current 
treatments for cancer like chemotherapy and radiation have negative side effects 
that harm the patient.  Conversely, PDT has few side effects, is minimally 
invasive, and targets tumor cells due to their interaction with LDL and the 
upregulation of LDL receptors on tumor cells.7  PDT requires three things; light, a 
photosensitizer, and molecular oxygen which separately are harmless but together 
can kill tumor cells.4  Clinically, the light can be added via a fiber optic cable to 
directly irradiate the tumor.1  A photosensitizer is a molecule that absorbs light 
and can transfer it to other compounds.16  When the photosensitizer gets excited 
by the correct wavelength of light, an electron becomes excited to the triplet 
state.16  When this happens, four things can occur.  The electron can fall down to 
the ground state and give off energy as fluorescence.  There are three mechanisms 
that can occur when the electron is excited, type I is when the electron gets 
transferred to molecular oxygen and superoxide or other reactive oxygen species 
are created.5  Type II reaction occurs when the electron falls to the ground state, it 
transfers energy to triplet oxygen and creates singlet oxygen.5  This reaction 
preferably occurs because the excited photosensitizer is in the triplet state and 
ground oxygen is in the triplet state as well, so the energy transfer is easy.16  
Singlet oxygen is both toxic in the cell and has a long half life, a little less than 
0.04 μsec, and a radius of effect around 0.02 μm.5  This small radius ensures that 
PDT is a very localized reaction.  Type III reaction is where the photosensitizer 
reacts directly with molecules in the cell by acting like an oxidizing agent.6  If the 
photosensitizer is bound to DNA, the nucleotides will be affected, most likely 
Guanine since it is the easiest nucleotide to oxidize.  All three of these 
mechanisms are toxic to the cell but type II is most sought after.  It is believed 
that singlet oxygen is what is toxic enough to kill the cell by reacting with cellular 
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components so this is the most sought after mechanism for the photosensitizer to 
undergo.12 
 The most well known, FDA approved, photosensitizer used is the 
hematoporphyrin derivative Photofrin (porfimer sodium).  Although Photofrin is 
being used in the clinic, it has some disadvantages.  These disadvantages include 
long-lasting skin photosensitivity and low singlet oxygen production at 630nm.8  
In addition, synthesis of Photofrin suffers from purification difficulties, dark 
toxicity, low tissue penetration of the light, and a high concentration of compound 
is required in order to be effective.13, 14  Due to the numerous issues with 
Photofrin, new photosensitizers are very desirable and are currently being sought. 
 The ideal photosensitizer should have several properties.  It should have minimal 
dark toxicity, high quantum yield of singlet oxygen production, tumor specificity, 
and absorption in the 700-800nm range.17  This red region is ideal since light 
scattering is minimal, the depth of penetration is deeper than wavelengths that are 
below 600nm (the range from 600-800nm is described as the PDT window), and 
the photosensitizer still can be excited by the low energy of the wavelength.17, 18   
 Porphyrins are currently being researched as potential photosensitizers due to 
their lack of dark toxicity, their strong absorption properties, and their tumor 
affinity.  Some porphyrins have already been proven to be more effective PDT 
substitutes for Photofrin however the absorption spectrum of thse porphyrins 
remains too high in energy and thus the required light cannot penetrate far into 
tissue.11  An additional attribute of porphyrins is their nuclear localization and 
specifically the ability of cationic porphyrins which have been shown to interact 
with DNA.10-11  Since generic porphyrins are insoluble in water, and require 
higher energy light to be activated, there is a need to synthesize new novel 
porphyrins that overcome these obstacles. 
 In this report we describe our attempt create a novel cationic porphyrin and the 
results of the synthesis.  We describe the synthesis and characterization by 1H 
NMR, UV/Vis spectroscopy, electrochemistry, and elemental analysis of a new 
polyisoquinol pyrrole complex with good synthetic yield and absorption 
properties.  We investigate the ability of ruthenated and methylated derivative of 
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the original complex to photocleave supercoiled plasmid DNA when irradiated 
with low-energy.  The ruthenated complex was successful at photocleaving DNA 
above 420nm, but not above 550nm.  The methylated complex was successful at 
photocleaving DNA above 550nm which provides us with a photosensitizer that 
can be excited using low energy light. 
 
Experimental Section 
 
 Materials.  A mercury arc lamp 300 watt [Newport Model 67005], 550nm filter 
[Newport Model 10LWF-550-B], 420nm filter [Newport FSR-GG420] were used 
for the photocleavage studies.  Tris(hydroxymethyl)-aminoethane (Tris Base) 
[Fischer], boric acid [Fischer], the plasmid pUC18 DNA [Bayou Biolabs], 
Hydrazine [Aldrich], Acetonitrile [Acros], Methanol [Fischer], Ethylene Glcyol 
[Acros], Methylene chloride [Fischer], Anhydrous methylene chloride [Acros], 5-
nitroisoquinoline [Acros], 4-fluorobanzaldehyde [Acros], Boron trifluoride 
etherate [Acros], Trifluoroacetic acid [Acros], Electrophoresis grade Agarose low 
EEO [Fischer}, Phosphazene base [Aldrich], Tetrabutylammonium 
hexafluorophosphate (Bu4NPF6, used as supporting electrolyte for 
electrochemistry) [Aldrich], ethyl isocyanoacetate [Acros], p-chloranil [Aldrich], 
neutral silica gel [Selecto Scientific] were used for the synthesis and 
electrochemical studies.  All elemental analyses were performed by Atlantic 
Microlab in Norcross, Ga.  Mass spectrometry was performed by The Ohio State 
University Mass Spectrometry and Proteomics facility.  Cis-Ru(bipy)2Cl2 was 
synthesized as previously described.19 
 
 Isoquinone pyrrole ester.  Isoquinone pyrrole ester was synthesized as 
previously stated.15  In a 250mL round bottom flask 2.32g (13.3 mmol) of 5-
nitroisoquinoline was added with 100mL of dry THF.  Massed 2.00g (17.7 mmol) 
of isocyanoacetate and then added it dropwise to the round bottom flask.  Added 
4.27mL (13.7 mmol) of phosphazene base and let the solution stir and reflux for 
24 hours.  The solution was black before and after refluxing.  After the solution 
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refluxed, 100mL of methylene chloride was added to wash it.  Added 150mL of 
deionized water to a separatory funnel and added the contents of the flask to the 
funnel and shook it up.  The contents separated and we collected the black lower 
layer in a beaker.  Added sodium sulfate to beaker to collect any excess water 
molecules and then decanted the solution into another beaker and let the solvent 
evaporate off.  Column chromatography of the solid was performed using 1% 
methanol in methylene chloride.  Collected orange band as it came off and used a 
rotator evaporator (rotovap) to remove the solvent.  Collected the solid in the 
beaker.  The solid was vacuum filtered and washed with methylene chloride.  
Final yield was 0.98 g. 
 
 Isoquinone pyrrole.  This compound was created as previously stated.15  Started 
the reaction by adding 0.90 g of isoquinoline ester into a three-necked round 
bottom flask with 1.1 g of KOH and 20mL of ethylene glycol.  Bubbled the flask 
under nitrogen for ten minutes.  Added 10 drops of hydrazine and refluxed at 195 
degrees Celsius for 30 minutes (Under nitrogen still).  Poured the mixture into 
ice/water which causes precipitation and vacuum filtered the precipitate.  Rinse 
the precipitate with water and vacuum filter overnight.  Final yield was 0.55 g. 
 
 Poly-isoquinone pyrrole.  Placed 0.36 g (2.1 mmol) of isoquinone pyrrole and 
100 microliters of dry methylene chloride in a three-neck flask and stirred the 
solution under nitrogen.  The flask was submerged in a dry ice/acetone bath.  
Then 230 microliters (2.14 mmol) of p-fluorobenzaldehyde and 87 microliters 
(0.69mmol) of boron trifluoride dietherate were added to the solution.  The 
solution was stirred under nitrogen in the dry ice/acetone bath for two hours while 
being protected from light.  After two hours, the flask was raised from the bath 
and continued to stir overnight at room temperature while still being protected 
from light.  The next morning, we added 0.52 g of p-chloranil and continued 
stirring at room temperature for one hour.  Poured the solution into another round 
bottom flask and rinsed the old flask with methylene chloride and then methanol.  
Rotovapped the flask to remove the solvent.  Using neutral silica gel with sand on 
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top, we performed column chromatography on the mixture using a 90/10 
methylene chloride methanol solution as eluent and collected a bright maroon 
purplish band.  Collected the solid and vacuum filtered it.  Final yield was 0.11 g 
of compound.  Anal. Calcd For C. 73.57, H 4.84, N 15.36.  Found: C 73.59, H 
4.87, N 15.60.  TOF MS ES+ (m/z; relative abundance): [C33H24N6O2] (537.9) 
 
 Ruthenation of poly-isoquinone pyrrole.  Added 25 mg (0.050mmoles) of poly-
isoquinol pyrrole, 73 mg (0.15 mmoles) and 5 mL of glacial acetic acid into a 
10mL round bottom flask.  Reflux and stir under nitrogen for thirty minutes.  
Rotovapped solution down and added 2 mL of ethanol.  Refluxed and stirred 
under nitrogen.  Added excess ammomium hexafluorophosphate to 125 mL of 
water.  Added reluxed product to solution and a red-brown precipitate .  Vacuum 
filtered overnight.  Dissolved with a little acetonitrile and then added solution to 
diethyl ether.  Vacuum filtered again and collected 74 mg.  Calculated for 
[C93H73O2N18Cl3F18P3Ru3·2H2O]  C, 47.05; H, 3.27; N, 10.62; F, 15.20  Found: 
C, 46.92; H, 3.25; N, 10.21; F, 15.22 
 
 Methylation of poly-isoquinone pyrrole.  Place 1μL of DMF; 20 ml of 
methylene chloride, 12 mg (.0223mmoles) of poly isoquinol pyrrole, and 170 μL 
(1.115 mmoles) of methyl tosylate into a 50mL round bottom flask.  Let stir at 
room temperature then reflux for 30 minutes.  Gravity filtered it, a purple 
precipitate was left while the filtrate was bright red.  Washed through with 
ethanol, then let evaporate to collect the solid.  Deep purple solid was too hard to 
scrap so we used two mL of DMSO and 23mL water to dissolve and dilute 
product.  Diluted to 100mL to a concentration of 74 μM.  Anal. Calcd For C, 
62.81; H, 4.96; N, 7.52.  Found: C, 62.51; H, 4.85; N, 7.67.  [C57H54N6O11S3] 
 
 NMR Spectroscopy.  1H NMR was performed by a Bruker 300MHz 
spectrometer using CDCl3 as the solvent and TMS as the internal standard. 
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 Electronic spectroscopy.  UV/vis spectra were recorded at room temperature 
using a Schimadzu 1501 photodiode array spectrophotometer with 2nm 
resolution.  Samples were run in a 1cm quartz cuvette. 
 
 Electrochemistry.  Cyclic voltammograms were recorded using a one-
compartment, three electrode cell, CH-Instruments, equipped with a platinum 
wire auxiliary electrode.  The working electrode was a 2.0 mm diameter platinum 
disk from CH-Instruments.  The working electrode was polished first using 0.30 
μm alumina polish (Buehler) and then sonicated for 20s prior to use.  Potentials 
were referenced to a Ag/Ag+ (0.010M, in acetonitrile) electrode.  The supporting 
electrolyte was 0.1M tetrabutylammonium hexfluorophosphate (Bu4NPF6) and the 
measurements were made in acetonitrile. 
 
 Plasmid Photocleavage.  Buffered solution of pUC18 and pUC18/complex II or 
complex III at a ratio of 10:1 bp/complex were placed in a quartz cuvette and 
irradiated with a 300W Mercury Arc Lamp (Newport) equipped with the 
appropriate filter.  Samples were taken at 10 minutes over an 80 minute period 
and run in 1% agarose gel by applying 224V for 45 minutes in approximately 
300mL of Tris buffer solution.  Gels were stained with ethidium bromide and 
photographed using UV illumination. 
 
 
Results and Discussion 
 
 The original reaction of the isoquinol pyrrole was designed to create a porphyrin 
ring with the aldehydes incorporated.  When we ran the elemental analysis, mass 
spectrum, NMR, and UV/vis spectrum we realized that we did not create a 
porphyrin.  The NMR looked very similar to the starting isoquinol pyrrole.  The 
UV/vis spectrum had a strong soret band but lacked any Q bands which should be 
there for a porphyrin.  The elemental analysis and mass spectrum made it clear 
that we had created a new novel compound that was not a porphyrin.  We decided 
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to try the reaction again and got the same results.  Since the aldehyde nor the 
boron trifluoride dietherate were not incorporated in the compound we wondered 
if they were necessary for the reaction to take place.  We first took out the 
aldehyde, reran the rest of the reaction, and the compound was not created.  Next 
we kept the aldehyde but took out the boron trifluoride dietherate and the 
compound was still not created.  Finally, we took out both the aldehyde and the 
boron trifluoride dietherate and the reaction was unsuccessful.  We know that 
both the aldehyde and the boron trifluoride dietherate are necessary for the 
reaction although we are unable to explain why or how the reaction takes place.  
We decided to test the compound due to its great absorption properties. 
 
Compound I     Compound II 
 
 Figure 1 shows the ultraviolet visible (UV/vis spec) spectroscopy that we 
obtained on the compound.  To get the compound in solution, we added methanol 
to dissolve the compound and then filled up the rest of the 25 mL flask with 
acetonitrile.  The spectroscopy was obtained at room temperature.  The red line is 
the compound in solution without acid and the blue line is the compound in 
solution with a couple drops of trifluoroacetic acid.  The red line has strong 
absorption from 500-600 nm and is very broad.  We propose that the broadness of 
the peak is due to stacking of the molecules in solution.  Since the compound is 
planar and very conjugated, hydrophobic interactions are possible between 
molecules.  The blue band is not broad and we believe that the positively charged 
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molecules do not interact as much and do not make the peak broad.  The blue 
band is red-shifted, or shifted to the right.  We believe that this could be due to 
two different hypotheses.  The first one is that the protonation of the hydroxyl 
group that is attached to the nitrogen ring without a double bond (right most 
nitrogen ring in the figure) creates a good leaving group.  The water molecule 
leaves and the adjacent hydrogen gets abstracted from the nitrogen to create a 
double bond.  The double bond increases the conjugation of the system that was 
previously not there and the increase in the conjugation requires lower energy to 
excite it (red-shift).  The other hypothesis is that protonating one of the isoquinol 
nitrogens creates an electronegative pull on the ring.  Since the rings are 
connected via single bonds, the conformation is continually shifting and changing.  
When the rings rotate they occasionally align with each other.  When the quinol 
nitrogen gets protonated, this increases the electronegativity of that ring and when 
it aligns with the adjacent ring interacts with the ring and makes that 
conformation preferable.  By making the conformation more preferable and 
probable, the rings can essentially increase the conjugation system by the 
interaction that occurs.  This increase in overlapping causes the red-shift. 
 
Figure 1. UV/Vis of Compound I. Red line is without acid. Blue line is after addition of 
TFA. 
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 Figure 2 shows the UV/vis and fluorescence of the compound.  The red line is the 
UV/vis and the green line is the fluorescence.  The fluorescence band is the result 
of exciting the compound at 530 nm.  The compound fluoresced well into the 
600-700nm range.  The fluorescence of this compound is a good sign for its 
availability to be used as a PDT agent. 
 
Figure 2.  Red line is the UV/Vis of Compound I.  Green line is the fluorescence of 
Compound I. 
 
 Cyclic voltammetry (CV) in the liquid phase was performed on the compound and 
the ruthenated compound.  In Figure 3,the CV of compound I is shown.  
Anodically, there is a large irreversible oxidation wave of the compound around 
0.8-1.0 V vs. Ag/AgCl.  Cathodically there is a one-electron reduction of the 
compound. 
Cyclic voltammetry of compound II is shown in Figure 4.  Anodically there is a 
reversible redox couple at 0.8 V vs. Ag/AgCl that was not present in the non-
ruthenated CV and is due to the Ru(III/II) couple.  It does not look reversible but 
that is because it is overlapped by the large irreversible wave of the ligand.  
Cathodically there is a reduction wave that wasn’t previously there that is due to 
the bipyridal groups that are coordinated to the rutheniums. 
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Figure 3. Cyclic voltammogram of compound I in acetonitrile with tetra-butly 
ammonium hexafluorophosphate as supporting electrolyte. The working electrode is 
glassy carbon, scan rate = 50 mV/s. 
 
Figure 4. Cyclic voltammogram of compound I in acetonitrile with tetra-butly 
ammonium hexafluorophosphate as supporting electrolyte. The working electrode is 
glassy carbon, scan rate = 50 mV/s. 
 
 Photocleavage studies were performed with aqueous solutions of circular plasmid 
DNA and the ruthenated compound at a ratio 10:1 DNA base pairs to compound.  
Samples were removed at ten minute intervals and gel electrophoresis was 
performed in order to determine the ability of the ruthenated compound to 
photocleave DNA.  There was a 420nm filter lens on the lamp.  This made sure 
that no wavelengths lower than 420nm were allowed to penetrate the cuvette.  The 
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lower on the gel the bands are means that the DNA are not nicked or less nicked.  
The first band (farthest left) is the control that contains just plasmid, water, and 
dye.  The second band (second farthest left) is the control that contains plasmid, 
water, dye, and compound before being irradiated with light and since the band is 
so far down, this means that the compound does not affect the DNA in the dark.  
Every other band is after a ten minute interval.  So the third band is after ten 
minutes, the fourth band is after twenty minutes or irradiation and so forth.  The 
ruthenated compound was able to efficiently nick the plasmid DNA completely 
after the full eighty minutes due to the lack of the lower band.  This is excellent 
data but the PDT window was not achieved.  When we put the 550nm filter, the 
ruthenated compound was not able to photocleave the plasmid DNA.  We propose 
that the addition of the rutheniums quenched the absorption properties of the 
ligand.  Due to the quenching, higher energy wavelengths are required for the 
type II photocleavage to occur.  This left shift of the absorption means that the 
compound is not in the PDT window and not ideal.  We decided to find a different 
way to increase the solubility of the compound that would not quench the 
absorption properties. 
        1           2           3         4        5           6         7         8           9        10 
 
Figure 5. Gel electrophoresis of circular plasmid DNA (pUC18) in the presence of 
complex I (lanes 2-10) and without complex I (lane 1) irradiated with a 300 W mercury 
arc lamp filtered to allow only light of 420 nm and higher to penetrate, samples taken at 
10 min intervals. 
To eliminate the luminescent quenching of the ruthenium polypyridyl groups but 
still maintain water solubility compound I was reacted with p-methyl-toluene 
sulfonate giving compound III. 
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 The methylated compound’s uv/vis and fluorescence is shown below.  The red 
band is just the methylated compound’s UV/vis.  It has strong absorption from 
450-650nm.  The blue band is the fluorescence of the compound which 
fluorescences well into the PDT window.  This graph implies that the methyl 
groups do not quench the absorption properties of the ligand.  Photocleavage 
studies are required to prove that the methylated compound can still perform 
photodynamic therapy in the PDT window. 
 
Figure 6.  UV/vis (red line) and fluorescence (blue line) of the methylated 
polyisoquinoline. 
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 Figure 7 displays the gel that was created during the photocleavage study when 
using compound III.  The ratio of base pairs to compound is 5:1 and we extracted 
samples over ten minute intervals again, then used gel electrophoresis to 
determine the efficiency of the compound to photocleave DNA.  We used a 
550nm filter for this experiment and the compound did not quench the absorption 
properties of the compound as shown by the nicked bands that did not travel as far 
in the gel.  Just like the ruthenated compound photocleavage experiment, the two 
controls are the same and are the farthest on the left and these lanes show that the 
DNA was not affected by the compound in the dark.  After eighty minutes of 
irradiation essentially all the plasmid is nicked.  Since the 550 nm filter was used, 
we know that no wavelength less than 550 nm was able to excite the compound so 
the compound was not quenched by the methyl groups and it is still able to be 
excited in the PDT window or very close to it.  This photocleavage study proves 
how important this compound is, it is water soluble and cleaves in the PDT 
window. 
        1          2           3         4         5          6          7          8          9        10 
 
Figure 7. Gel electrophoresis of circular plasmid DNA (pUC18) in the presence of 
complex I (lanes 2-10) and without complex I (lane 1) irradiated with a 300 W mercury 
arc lamp filtered to allow only light of 550 nm and higher to penetrate, samples taken at 
10 min intervals. 
 
Conclusions 
 The initial desired compound was not obtained, instead a novel compound with an 
extended conjugated system has been synthesized in high yield and with great 
absorption properties.  Ruthenation of the compound has been shown to photonick 
plasmid DNA when irradiated with wavelengths greater than 420 nm.  When 
irradiated with wavelengths greater than 550nm the rutheniums have been shown 
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to quench the absorption properties and disrupt the ability of the molecule to 
photocleave the plasmid DNA.  Methylation of the compound yielded a 
compound that was water soluble  with great absorption and fluorescence in the 
PDT window.  The methylated compound photonicked plasmid DNA at 
wavelengths longer than 550 nm which means that the addition of the methyl 
groups do not quench the absorption of the ligand.  Further studies are being 
performed to elucidate the mechanism of the reaction with the goal of 
understanding what is happening chemically and to synthesize more of these 
novel compounds to be used in PDT.  Also, to determine the PDT effectiveness of 
the compound in normal cells and cancer cells. 
 
Acknowledgement 
 
 The author would like to thank his advisor, Dr. Shawn Swavey for his amazing 
guidance, teaching, and friendship.  I would also like to thank Dr. Benin for his 
help with Boron NMR and always being willing to answer any questions that 
arose.  Finally, I would like to thank the University of Dayton Chemistry and 
Honors departments for their generous contributions to this project. 
 
 
References 
1. Frazier, Claude C. "Photodynamic Therapy In Dermatology." International 
Journal Of Dermatology 35.5 (1996): 312. Publisher Provided Full Text 
Searching File. Web. 24 Mar. 2014. 
2. Michel, et al. "Photodynamic Therapy (PDT) For Oesophageal Cancers." European 
Journal Of Cancer Care 8.(1999): 20-24.Academic Search Complete. Web. 24 
Mar. 2014. 
3. Hsi, R.A., D.I. Rosenthal, and E. Glatstein. "Photodynamic Therapy In The 
Treatment Of Cancer: Current State Of The Art." Drugs 57.5 (1999): 725-
734. SPORTDiscus with Full Text. Web. 24 Mar. 2014. 
4. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl 
Cancer Inst. 1998;90:889-950. 
5. Hsi, R.A., D.I. Rosenthal, and E. Glatstein. "Photodynamic Therapy In The 
Treatment Of Cancer: Current State Of The Art." Drugs 57.5 (1999): 725-
734. SPORTDiscus with Full Text. Web. 24 Mar. 2014. 
6. Allison, Ron R., and Claudio H. Sibata. "Oncologic Photodynamic Therapy 
Photosensitizers: A Clinical Review." Photodiagnosis & Photodynamic 
Therapy 7.2 (2010): 61. Supplemental Index. Web. 25 Mar. 2014. 
7. J.C., Mazière, Morlière P., and Santus R. "Invited Review: New Trends In 
Photobiology. The Role Of The Low Density Lipoprotein Receptor Pathway In 
The Delivery Of Lipophilic Photosensitizers In The Photodynamic Therapy Of 
P a g e  | 15 
 
Tumours." Journal Of Photochemistry & Photobiology, B: Biology 8.(n.d.): 351-
360. ScienceDirect. Web. 24 Mar. 2014. 
8. Agostinis, Patrizia, et al. "Photodynamic therapy of cancer: an update." CA: a 
cancer journal for clinicians 61.4 (2011): 250-281. 
9. Sharman, W. M.; Allen, C.M.; van Lier, J.E. Drug Discovery Today 1999, 4, 507. 
10. DNA Interaction and Photocleavage Properties of Porphyrins Containing Cationic 
Substituents at the Peripheral Position Sashikumar Mettath,†, Benjamin R. 
Munson,† and, and Ravindra K. Pandey*,†,‡Bioconjugate Chemistry 1999 10 (1), 
94-102 
11. In Vitro Demonstration of Apoptosis Mediated Photodynamic Activity and NIR 
Nucleus Imaging through a Novel Porphyrin Suneesh C. Karunakaran, P. S. 
Saneesh Babu, Bollapalli Madhuri, Betsy Marydasan, Albish K. Paul, Asha S. 
Nair, K. Sridhar Rao, Alagar Srinivasan, Tavarekere K. Chandrashekar, Ch. 
Mohan Rao, Radhakrishna Pillai, and Danaboyina Ramaiah ACS Chemical 
Biology 2013 8 (1), 127-132 
12. Activatable Photosensitizers for Imaging and Therapy Jonathan F. Lovell, Tracy 
W. B. Liu, Juan Chen, and Gang Zheng Chemical Reviews 2010 110 (5), 2839-
2857 
13. O'Connor, Aisling E., William M. Gallagher, and Annette T. Byrne. "Porphyrin 
And Nonporphyrin Photosensitizers In Oncology: Preclinical And Clinical 
Advances In Photodynamic Therapy." Photochemistry & Photobiology 85.5 
(2009): 1053-1074. Academic Search Complete. Web. 26 Mar. 2014. 
14. Yang, Pei-Wen, et al. "The Effects Of Photofrin-Mediated Photodynamic Therapy 
On The Modulation Of EGFR In Esophageal Squamous Cell Carcinoma 
Cells." Lasers In Medical Science 28.2 (2013): 605-614. MEDLINE with Full 
Text. Web. 26 Mar. 2014. 
15. Lash, Timothy D., and Virajkumar Gandhi. "Porphyrins With Exocyclic Rings. 
15. Synthesis Of Quino- And Isoquinoporphyrins, Aza Analogues..." Journal Of 
Organic Chemistry 65.23 (2000): 8020. Academic Search Complete. Web. 24 
Mar. 2014. 
16. Ormond, Alexandra B., and Harold S. Freeman. "Dye Sensitizers For 
Photodynamic Therapy." Materials (1996-1944) 6.3 (2013): 817-840. Academic 
Search Complete. Web. 27 Mar. 2014. 
17. Pushpan, S K, et al. "Porphyrins In Photodynamic Therapy - A Search For Ideal 
Photosensitizers." Current Medicinal Chemistry. Anti-Cancer Agents 2.2 (2002): 
187-207. MEDLINE with Full Text. Web. 27 Mar. 2014. 
18. Barun, V., et al. "Absorption Spectra And Light Penetration Depth Of Normal 
And Pathologically Altered Human Skin." Journal Of Applied Spectroscopy 74.3 
(2007): 430-439. Academic Search Complete. Web. 27 Mar. 2014. 
19. Sullivan, B.P.; Salmon, D.J.; Meyer, T.J. Inorg. Chem. 1978, 17, 3334. 
 
